Hypertrophic Cardiomyopathy Mimicking a Primary Cardiac Tumor: Case Report and Review of Molecular Genetic Findings

Heather L Williams1, Tara Mahar2

  • 1M2 at the Jacobs School of Medicine at the University at Buffalo, Buffalo, NY.

Insights

Sudden cardiac death (SCD) risk in hypertrophic cardiomyopathy (HCM) is highlighted. A rare ALPK3 gene mutation caused SCD in a young, asymptomatic patient, revealing new pathological insights.

Area of Science:

  • Cardiology
  • Genetics
  • Pathology

Background:

  • Sudden cardiac death (SCD) is a significant risk in hypertrophic cardiomyopathy (HCM), particularly in young, asymptomatic individuals.
  • Common genetic causes of HCM include mutations in MYBPC3 and MYH7 genes.
  • The ALPK3 gene is implicated in HCM, often associated with late-onset disease or pediatric cases with distinct deformities.

Purpose of the Study:

  • To report a unique case of SCD in a young, asymptomatic patient with hypertrophic cardiomyopathy.
  • To investigate the role of a specific ALPK3 gene mutation in this case.
  • To describe novel gross pathological findings associated with ALPK3-related HCM.

Main Methods:

  • Case report and clinical data review.
  • Genetic sequencing to identify mutations.
  • Gross pathological examination of cardiac tissue.

Main Results:

  • The patient experienced SCD due to HCM.
  • A specific ALPK3 gene mutation was identified.
  • Unusual gross pathological features of the heart were observed, not previously documented in literature.

Conclusions:

  • This case expands the understanding of ALPK3 gene mutations in HCM and SCD.
  • It highlights the potential for severe cardiac events even in the absence of typical symptoms or deformities.
  • The findings underscore the importance of genetic testing and detailed pathological analysis in HCM cases.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
564
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
828
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761